Long-Term Experience of Self-Injection Therapy with Prostaglandin E₁ for Erectile Dysfunction

Abstract

A total of 42 evaluable patients 36-80 years old were treated with intracavernous injection of prostaglandin E₁ for erectile dysfunction. They reported retrospectively via a questionnaire their long-term experience of this method. Twenty-four patients (57%) were after 46.9 months still using the technique, while 18 patients (43%) had abandoned the method after 21.4 months of use. No major complications were observed or reported.

Key-words:

• Erectile dysfunction
• prostaglandin E₁